Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Nasdaq Real Time Price USD

Vivos Therapeutics, Inc. (VVOS)

2.6300
-0.0800
(-2.95%)
At close: April 25 at 4:00:00 PM EDT
2.7100
+0.08
+(3.04%)
After hours: April 25 at 4:13:52 PM EDT
Advanced Chart
Loading Chart for VVOS
  • Previous Close 2.7100
  • Open 2.6400
  • Bid 2.5400 x 100
  • Ask 2.6600 x 100
  • Day's Range 2.5535 - 2.6600
  • 52 Week Range 1.9100 - 6.2800
  • Volume 54,134
  • Avg. Volume 122,639
  • Market Cap (intraday) 15.961M
  • Beta (5Y Monthly) 7.28
  • PE Ratio (TTM) --
  • EPS (TTM) -2.2200
  • Earnings Date May 12, 2025 - May 16, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 5.85

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.

www.vivos.com

109

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

More about Vivos Therapeutics, Inc.

Recent News: VVOS

View More
View More

Performance Overview: VVOS

Trailing total returns as of 4/25/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

VVOS
38.69%
S&P 500 (^GSPC)
6.06%

1-Year Return

VVOS
6.91%
S&P 500 (^GSPC)
9.44%

3-Year Return

VVOS
93.95%
S&P 500 (^GSPC)
28.61%

5-Year Return

VVOS
98.51%
S&P 500 (^GSPC)
94.77%

Compare To: VVOS

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

VVOS
Vivos Therapeutics, Inc.
2.6300
-2.95%
Mkt Cap 15.961M
Industry Medical Devices
SINT
Sintx Technologies, Inc.
2.5800
-5.15%
Mkt Cap 6.841M
Industry Medical Devices
TNON
Tenon Medical, Inc.
1.1700
+1.74%
Mkt Cap 7.254M
Industry Medical Devices
INBS
Intelligent Bio Solutions Inc.
1.2900
-0.77%
Mkt Cap 8.819M
Industry Medical Devices
VTAK
Catheter Precision, Inc.
0.2898
+1.76%
Mkt Cap 2.686M
Industry Medical Devices
IINN
Inspira Technologies Oxy B.H.N. Ltd.
0.6129
-3.33%
Mkt Cap 16.243M
Industry Medical Devices
AEMD
Aethlon Medical, Inc.
0.3813
+1.71%
Mkt Cap 6.134M
Industry Medical Devices
HSCS
HeartSciences Inc.
3.1986
-3.07%
Mkt Cap 3.491M
Industry Medical Devices
HSDT
Helius Medical Technologies, Inc.
0.2920
-2.24%
Mkt Cap 1.814M
Industry Medical Devices
TNONW
Tenon Medical, Inc.
0.0197
-1.50%
Mkt Cap -
Industry Medical Devices
XAIR
Beyond Air, Inc.
0.2177
+3.67%
Mkt Cap 19.218M
Industry Medical Devices

Statistics: VVOS

View More

Valuation Measures

Annual
As of 4/25/2025

  • Market Cap

    15.49M

  • Enterprise Value

    10.74M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.88

  • Price/Book (mrq)

    1.95

  • Enterprise Value/Revenue

    0.71

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -74.09%

  • Return on Assets (ttm)

    -53.68%

  • Return on Equity (ttm)

    -266.25%

  • Revenue (ttm)

    15.03M

  • Net Income Avi to Common (ttm)

    -11.14M

  • Diluted EPS (ttm)

    -2.2200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    6.26M

  • Total Debt/Equity (mrq)

    19.01%

  • Levered Free Cash Flow (ttm)

    -8.84M

View More

Research Analysis: VVOS

View More
View More

Company Insights: VVOS

Research Reports: VVOS

View More
View More

People Also Watch

ABVC ABVC BioPharma, Inc.
0.9765
+7.19%
 
VRPX Virpax Pharmaceuticals, Inc.
0.2460
-15.90%
 
RNAZ TransCode Therapeutics, Inc.
0.3800
-5.00%
 
PALI Palisade Bio, Inc.
0.7200
-2.11%
 
TPST Tempest Therapeutics, Inc.
7.76
-3.60%
 
ADTX Aditxt, Inc.
2.3000
0.00%
 
ENSC Ensysce Biosciences, Inc.
3.2900
-0.60%
 
MINM FiEE, Inc.
0.9000
+9.74%
 
LIXT Lixte Biotechnology Holdings, Inc.
1.2800
-7.25%
 
PRFX PainReform Ltd.
2.3500
+1.29%
 
SNOA Sonoma Pharmaceuticals, Inc.
4.2300
+9.59%
 
PBLA Panbela Therapeutics, Inc.
0.3210
+10.69%
 
DRMA Dermata Therapeutics, Inc.
0.7390
-1.47%
 
PTPI Petros Pharmaceuticals, Inc.
0.0540
+5.47%
 
DBGI Digital Brands Group, Inc.
9.25
-0.22%
 
GRTX Galera Therapeutics, Inc.
0.0250
0.00%